Log In
Print
BCIQ
Print
Print this Print this
 

CYC065

  Manage Alerts
Collapse Summary General Information
Company Cyclacel Pharmaceuticals Inc.
DescriptionSecond-generation inhibitor of cyclin dependent kinases (CDKs) 2E, 2A, 7 and 9
Molecular Target
Mechanism of Action 
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today